SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ORMP

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

US · Delayed Price · Currency is USD
Also listed: ORMP.TAHealthcare · Biotechnology
$3.57-$0.12 (-3.25%)
 
Market cap
$155M
Insider Score
Health Score
Analyst consensus
Listed since
May 1, 2007
Website
Market Cap$155.24M+37.8%
Revenue (ttm)$0-100.0%
Net Income$144.88M+230.4%
EPS$3.41+244.4%
Shares Out43.49M
PE Ratio1.02
Forward PEn/a
Dividend$0.25(7.00%)
Ex-Dividend DateJan 16, 2026
Volume285,666
Open$3.65
Previous Close$3.69
Day's Range$3.54 - $3.71
52-Week Range$2.52 - $5.47
Beta1.28
AnalystsBuy
Price Targetn/a
Earnings DateMar 25, 2027

About ORMP

Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical trials for patients with diabetes. Oramed is also advancing ORMD-0901, an oral glucagon-like peptide-1 (GLP-1) capsule, which has concluded Phase I clinical trials for the treatment of type 2 diabetes. Additionally, an oral leptin capsule for weight loss is currently under development. The firm was originally incorporated as Integrated Security Technologies, Inc., before officially changing its name to Oramed Pharmaceuticals Inc. in April 2006.

Address
1185 Avenue of the Americas, New York City, NY, 10036, US
Market Cap
155 million
Employees
13
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$836.96K
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Sound
From ORMP’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-3.25%
5 Days
-3.51%
1 Month
-13.35%
6 Months
-10.53%
1 Year
+37.84%

$ORMP stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ORMP holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ORMP's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ORMP Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ORMP patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ORMP from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ORMP

IWMiShares Russell 2000 ETF$3.09M
IWNiShares Russell 2000 Value ETF$1.14M
VTWOVanguard Russell 2000 ETF$846.52K
IWCiShares Micro-Cap ETF$380.61K
SILXETFMG Prime 2x Daily Junior Silver Miners ETF$325.28K
VALTETFMG Sit Ultra Short ETF$319.37K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from ORMP’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
3
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

+0.0 since Oct 4
0255075100Oct 4 — Insider Score 0.0Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

FSEVFidelity Enhanced Small Cap Value ETF0.05%

Weight is the stock’s share of each fund’s holdings.